Discontinued — last reported Q4 '25
Viatris Share Buybacks decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $175.40M to $0.00.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $250.00M | $250.00M | $175.40M | $175.00M | $67.90M | $85.10M | $0.00 |
| QoQ Change | — | — | — | — | — | — | — | — | +0.0% | -29.8% | -0.2% | -61.2% | +25.3% | -100.0% |
| YoY Change | — | — | — | — | — | — | — | — | +0.0% | -29.8% | — | — | — | -100.0% |